Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1986-9-25
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0340-3696
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
278
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
335-6
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3740944-Adult,
pubmed-meshheading:3740944-Behcet Syndrome,
pubmed-meshheading:3740944-Female,
pubmed-meshheading:3740944-Humans,
pubmed-meshheading:3740944-Interferon Type I,
pubmed-meshheading:3740944-Male,
pubmed-meshheading:3740944-Middle Aged,
pubmed-meshheading:3740944-Recombinant Proteins
|
pubmed:year |
1986
|
pubmed:articleTitle |
Behçet's syndrome: treatment with recombinant leukocyte alpha-interferon.
|
pubmed:publicationType |
Journal Article
|